Co-delivery of icariside II and doxorubicin by self-assembled carrier-free nanofibers for anti-lung cancer therapy

A novel carrier-free nanofiber system self-assembles from icariside II and doxorubicin via hydrogen bonding, enabling controlled release, enhanced uptake, and superior anti-lung cancer efficacy compared to single-drug therapies.